自引率: 8.4%
被引量: 10286
通过率: 暂无数据
审稿周期: 2.47
版面费用: 暂无数据
国人发稿量: 83
投稿须知/期刊简介:
Published by Elsevier Science. ISSN: 1368-8375.<br /><br />Oral Oncology is an international interdisciplinary journal which draws together for the first time issues relating to the aetiopathogenesis, epidemiology, prevention and management of oral and perioral tumours and of oral disease in patients with malignancies. Papers are invited on the following aspects of cancers arising in the lip, tongue, mouth, salivary glands, pharynx, and the related bones, soft tissues, and lymph glands. (1) Natural history of oral cancer and pre cancer, basic pathology, mestastatic mechanisms. (2) Cellular and molecular markers for diagnosis and prognosis, oncogenes, viruses, growth factors, and adhesion molecules. (3) Epidemiology, risk factors, prevention, screening, and intervention. (4) Advances in imaging and other functional diagnostic modalities. (5) Surgical advances, lasers, photo dynamic therapy, cyro surgery, micro vascular surgery. (6) Multimodality treatment, radiotherapy, chemotherapy, immunotherapy, gene therapy. (7) Advances in reconstruction and rehabilitation, grafts, alloplasty, bone and connective tissue biology, osteoradionecrosis. (8) Teamwork in cancer care, quality of life, nursing, speech and swallowing therapy, nutrition, counselling, pain control, terminal care. (9) Oral effects of tumours at both local and distant sites and their treatment. Research data may be submitted as a paper, short communication or letter. The journal will consider negative results from well designed studies, which may be published as short communications or letters. Letters may be published as short communications. Letters that comment on an article previously published in the same journal or that express a viewpoint about oncology are also invited. All published papers and short communications, and selected letters containing research data are peer reviewed.
期刊描述简介:
Oncogene covers all aspects of the structure and function of oncogenes, especially: Cellular oncogenes and their mechanism of activation Structure and function of their encoded proteins Oncogenes of the DNA and RNA tumour viruses The molecular oncology of human tumours Tumour suppressor genes Growth regulatory genes Cell cycle control Growth factors and receptors Apoptosis.
-
The tumor cell killing capacity of head and neck cancer patient-derived neutrophils depends on tumor stage, gender and the antibody isotype.
被引量:- 发表:1970
-
Pralsetinib as neoadjuvant therapy for RET-Altered differentiated thyroid cancer: Two case reports.
被引量:- 发表:1970
-
Impact of post-operative transoral robotic surgery hemorrhage on adjuvant treatment delays in patients with oropharyngeal squamous cell carcinoma.
被引量:- 发表:1970
-
Commentary on "Impact of high-risk EBV strains on nasopharyngeal carcinoma gene expression.".
被引量:- 发表:1970
-
Commentary on "Predictive value of CXCL1(+)_FAP(+) phenotype in CAFs for distant metastasis and its correlation with PD-L1 expression in locoregionally advanced nasopharyngeal carcinoma patients".
被引量:- 发表:1970